New composition, useful for treating central nervous system diseases, comprises an antibody linked to a linear peptide and is able to cross the blood-brain barrier

摘要

A composition (A), comprising at least one antibody (Ab), or its fragment, linked to at least one linear peptide (P) that is derived from protegrins or tachyplesins, or includes a transduction domain, is new. An Independent claim is also included for a nucleic acid (I) that encodes (A) where this is a fusion protein.